United States Sepsis Diagnosis Market Report 2017 - Research and Markets

DUBLIN--()--The "Sepsis - Diagnosis Report" report has been added to Research and Markets' offering.

In 2014, US healthcare spending exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. Informed by real-world data from an Electronic Health Record (EHR) database of clinical and administrative records spanning 273 million encounters for 60 million patients in 600+ hospitals across the US, this report estimates 30% of all hospital discharges involve treatment of infectious organisms.

Sepsis is responsible for an estimated 12% of all hospital stays. At an average cost of $15,500 per occurrence, we estimate that hospitalizations for severe infections account for $212 billion in annual spending or 7% of total healthcare expenditure. In this report, we conduct an in-depth analysis of sepsis patient characteristics, costs, and laboratory testing.

Gram-positive bacteria are the likely causative agents of most sepsis infections. From 2010-2015, drug resistant organisms caused an astonishing 40% of bacterial sepsis infections. Hospital-Treated Sepsis Part 1: Diagnosis is part one of a two-part series on hospital-treated sepsis.

This report provides quantitative, objective data focused on the diagnosis of sepsis requiring hospitalization captured by hospitals contributing to Cerner Health Facts. This data provides real-world patient encounters and reflects real physician diagnostic decisions and encounter characteristics (e.g. admissions and lab testing) in key areas, such as antibiotic resistant pathogens.

Key Topics Covered:

1. Outline

2. Executive Summary

3. Incidence and Impact of Disease

  • Incidence
  • Length of Stay
  • Total Cost

4. Patient Demographics

  • Age
  • Insurance type
  • Gender
  • Region
  • Mortality
  • Comorbid Conditions

5. Patient Segmentation by Diagnostic Testing

  • Causative Etiologic Agent

6. Length of Stay and Cost by Patient Segment

  • Age at Admission
  • APACHE II Score
  • First Care Setting

7. Patient Flow through the Hospital

  • Admission Site
  • Lab Testing
  • Lab TAT
  • Results
  • Etiology

8. Drug Resistant Sepsis

  • Current Trends
  • Costs
  • Comorbidity
  • LOS
  • Mortality

9. Database Overview

10. Methodology

For more information about this report visit https://www.researchandmarkets.com/research/z682s9/sepsis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Disease Testing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Disease Testing